Friday, November 17, 2017 2:53:45 PM
is selling shares of Worlds Online Inc( which is now Marimed-->MRMD)
and have stated as such through a press release they sent through Accentuate PR to fund operations,
and in the 10-Q it states they sold shares of Worlds Online Inc( which is now Marimed)
That the stake in Worlds Online Inc (Marimed) is currently worth the amount of accrued expenses, thus giving a way to pay them without dilution which the company seems to be reluctant to dilute.
That obviously somebody does believe in the WDDD lawsuit to the tune of $750,000.00 so much so they deferred payments until 2019 OR a settlement/jury award of pending ATVI infringement lawsuit.
That Susman and Godfrey have an agreement with WDDD to represent them in District Court after they did over 9 months of due diligence and took the case on contingency.
That we have a favorable markman.
That WDDD survived PTAB death squad
That current CAFC IPR STATS (apples to apples) point to about a 95% chance of returning to district court.
That there is a minimum of an 8% WDDD gets all of its claims back according to documented CAFC IPR STATS. That is before Oil States decision from SCOTUS is taken into account being as it is highly probable that decision will come down before WDDD CAFC does being as their oral arguments are on Nov 27th and WDDD won't be on a calendar till Jan at the earliest
That as the timeline becomes more solid and uncertainty or just time is reduced (based on past performance of not only WDDD history, but the entire IP sector) the PPS of shares involved rise.
Recent WDDD News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:34:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM